TRPM2 and glioblastoma: The results suggested that the patients with a high TRPM2 expression had shorter survival times compared with those with low TRPM2 expression in ACC, BRCA, GBM, HNSC, KIRC, LAML, LGG, LIHC, LUSC, OV, STAD, TGCT, THYM, UCS, and UVM (Figure 3A).